StockData
Beam Therapeutics Inc. logo

Beam Therapeutics Inc. (BEAM) stock

BEAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/304% below fair value
$22.83−1.20 (-4.99%)

Close on Nov 13, 2026Market cap $2.36BP/E –Yield –

Earnings

Beam Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 23, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$307.00K
EPS, Q3 FY2026
-$1.28
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Beam Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 23, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 3, 2026before the open$307.00K–-$1.28Release
Q2 FY2026ended Jun 30, 2026Aug 4, 2026before the open–––Release
Q1 FY2026ended Mar 31, 2026May 7, 2026before the open–––Release
Q4 FY2025ended Dec 31, 2025Feb 24, 2026before the open$114.11M+279.5%$2.33Release
Q3 FY2025ended Sep 30, 2025Nov 4, 2025before the open–––Release
Q2 FY2025ended Jun 30, 2025Aug 5, 2025before the open$8.47M-28.1%-$1.00Release
Q1 FY2025ended Mar 31, 2025May 6, 2025before the open–––Release
Q4 FY2024ended Dec 31, 2024Feb 25, 2025before the open$30.07M-90.5%-$1.09Release
Q3 FY2024ended Sep 30, 2024Nov 5, 2024before the open–––Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024before the open$11.77M-41.5%-$1.11Release
Q1 FY2024ended Mar 31, 2024May 7, 2024before the open$7.41M-69.4%-$1.21Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Beam Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Beam Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Beam Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Results
  7. Results
  8. Results
  9. Results
  10. News
  11. Update
  12. Results
  13. Results
  14. Results
  15. Update

See a number that looks wrong?